Delivery Order SPE2DR25D3015-SPE2DR26F4FK2
- Not listed
- The Defense Logistics Agency awarded a $12,673.62 delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price contract, which involves no set-aside designation, represents a competitively awarded delivery order under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,279.87 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $27,132.48 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Gemtesa 75 mg tablets (90-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by December 3, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gemtesa 75 mg tablets (30-count units) with a ceiling value of $1,389.38. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $48,927.46 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on April 23, 2025, with an ultimate completion date of April 24, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) with a ceiling value of approximately $10K. This non-set-aside contract award, issued on December 4, 2025, represents a firm fixed price delivery order with an ultimate completion date of December 5, 2025. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $33,238.55. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $37,071.79 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Gemtesa 75 mg tablets (90-count units), with completion scheduled for October 30, 2025. The contract employs firm fixed pricing with no small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $17,747.75 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,230.90 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FK2Delivery Order
The Defense Logistics Agency awarded a $17.2K delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This competitive award, which is non-set-aside, represents a firm fixed-price delivery order with performance concluding by December 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a primary pharmaceutical distributor for federal medical procurement. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements across multiple therapeutic domains through competitive awards reflecting both small-value and substantial orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 12/11/25 |